Profile
Andreas Sommer served as President & Chief Executive Officer at Celtrix Pharmaceuticals, Inc. and Chief Scientific Officer at Insmed, Inc. He also worked as Secretary & Vice President-Research at Auspex Pharmaceuticals, Inc. and Vice President-Research & Development at BioGrowth, Inc. Sommer holds a doctorate degree from the University of California, Davis and undergraduate and graduate degrees from the Swiss Federal Institute of Technology.
Former positions of Andreas Sommer
| Companies | Position | End |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | President | 20/10/2013 |
BioGrowth, Inc. | Chief Tech/Sci/R&D Officer | - |
Celtrix Pharmaceuticals, Inc.
Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops potential therapeutic products | President | - |
| INSMED INCORPORATED | Chief Tech/Sci/R&D Officer | - |
Training of Andreas Sommer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celtrix Pharmaceuticals, Inc.
Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops potential therapeutic products | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
BioGrowth, Inc. |
- Stock Market
- Insiders
- Andreas Sommer
















